Doi R, Hosotani R, Inoue K, Fujii N, Yajima H, Rayford P L, Tobe T
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Biochem Biophys Res Commun. 1990 Jan 15;166(1):286-92. doi: 10.1016/0006-291x(90)91943-m.
The receptor binding of CCK analogues was determined in terms of the inhibition of [125I]CCK binding in isolated rat pancreatic acini. The inhibition curve produced by CCK-8 showed the same feature as that produced by synthetic human CCK-33. The relative potency values of CCK analogues to half-maximally inhibit specific CCK binding were calculated; CCK-8 was equal to human CCK-33, 3-fold stronger than natural porcine CCK-33 and 39, and 700-fold stronger than the unsulphated form of synthetic human CCK-33. Our data suggest that CCK-33, one of the longer molecular forms of CCK, is as important as CCK-8 in the mechanism of physiological actions of CCK.